2026年度入圍的參賽者

2026年Lush獎項已從25個國家的60項提名項目中選出決選名單。

獲獎名單將於五月頒獎典禮上揭曉。

我們很抱歉此頁面尚未完全翻譯。

 

科研獎

Biomechanics Research Unit, GIGA institute, University of Liège
Belgium
Mapping physiology: A systems biology approach for the development of alternative methods in toxicology

Biosensing, Microfluidics, and Microsystems Team
USA

Next-Generation Sensor-Integrated Human Organ Chips for Biomedical and Women’s Health Research

CN Bio Innovations
UK
Predictive in vitro human organ models to reduce reliance on animal testing for pharmacokinetic and safety studies in drug discovery and development.

Curi Bio
USA
3D Quantitative Neuromuscular Junction Platform for Botulinum Neurotoxin Potency Assessment

Health and Environmental Sciences Institute
USA
The Omics for Assessing Signatures for Integrated Safety (OASIS) Consortium

Dr Ana Carolina Migliorini Figueira
Brazil
Building Brazil’s Capacity in Animal-Free Toxicology Through Human-Relevant Organ-on-a-Chip Platforms

MPSlabs, ESQlabs GmbH
Germany
Digital Twins of Organ-on-Chip Systems for Animal-Free PK and Liver Safety Testing

NGRA team/Lhasa Limited
UK
Replacing animal use in developmental and reproductive toxicity assessments through an in silico AOP framework

ProtoQSAR, S.L.
Spain
DockTox: Targeting molecular initiating events in organ toxicity through molecular docking.

Qureator, Inc
USA

Qureator’s organ-on-chip technology shifts away from animal testing in oncology drug discovery: 1st IND approval by US FDA solely based on human in vitro efficacy data for cancer

Prof Dr Wei Shi
China
AI-Driven Identification of Endocrine-Disrupting Chemicals

Team OUR medium
Sweden
Xeno-free universal cell culture medium for human cells

Tulane University (Dr Hao Zhu)
USA
Hybrid non-animal modeling of hepatotoxicity

 


重大科學合作計畫

AFSA: Animal-Free Safety Assessment Collaboration
Belgium

APCRA: Accelerating the pace of chemical risk assessment
Finland

ICCVAM Validation Workgroup Report on Validation and Qualification of NAMs
USA

International Collaboration on Cosmetics Safety
USA

 


公民意識獎

Animal-Free Science Advocacy
Australia
Honour Me With a Name

Animal Justice
Canada
Shutting Down St. Joseph’s Hospital Dog Lab & Sparking New Dog and Cat Testing Laws

Beagle Freedom of Project
USA
Ending Animal Testing: One Lab at a Time

Camp Beagle
UK
Camp Beagle

Comité scientifique Pro Anima
France
Pro Anima: Bridging Non-Animal Science and Society

Justify
USA
The Human Cost of Animal Research

Oltre la Sperimentazione Animale (OSA)
Italy
Catalyzing Change: How OSA is transforming Public Awareness in Italy

Omica Research and Innovation
Türkiye
Animal-Free Testing Explained Series

Organization for animal rights and the environment EVA
Bosnia and Herzegovina
Animal-Free Education Reform for Biomedical Faculties in Bosnia and Herzegovina

Te Protejo
Chile
‘More than a number’ campaign

 


政治倡議獎

Animal Free Research UK
UK
Herbie’s Law: A Landmark Step Towards Ending Animal Testing

Lindsey Borton and Dr Kelly Coleman
USA

Science-Driven Advocacy to Eliminate the Rabbit Pyrogen Test for Medical Devices

Convergence Animaux Politique
France
Driving policy change to reduce animal testing and promote NAMs in France

Environment & Animal Society of Taiwan (EAST)
Taiwan
Phasing out Animals Tests from Taiwan’s Health Food Claims

IG Tierversuchsverbots-Initiative
Switzerland
Animal testing-free future

JHU Cardiovascular Stem Cell Center
USA
Legislating Replacement: Establishing Global IEC Standards for Human-Based Cardiac Safety Testing

Dr Karynn Capilé
Brazil
Replacing animals in rabies diagnosis in Brazil

Te Protejo
Chile
Advocacy work to banning animal testing for cosmetics in Latin America

 


培訓獎

Animal Free Research UK
UK
The Recombinant Antibodies & Mimetics Database

Center for Alternatives to Animal Testing
USA
CAAT Education Program

Centre for Predictive Human Model Systems
India
Active Frameworks Engaging Indian Regulators and Funding Agencies in NAMs Integration

Computer Aided Therapeutic Discovery and Design Platform (CAT2D)
Nigeria
A Pedagogical AI-Driven Framework for Bioactivity-Guided Computational Toxicology and Non-Animal Risk Assessment for Nigerian Regulators and Graduate Students

Dr Silvya Engler
Brazil
Advancing Non-Animal Toxicology Through Large-Scale Training and Open-Access Human Skin Models in Brazil

ESTIV Board
Netherlands
ESTIV Applied Training Course on Non-Animal Methods in Toxicology

Fórum Nacional de Proteção e Defesa Animal
Brazil
Training and empowering Animal Protection Representatives in Brazilian Ethics Committees

Laboratorio de Métodos Alternativos
Argentina
Advancing Alternative Methods in Argentina and LATAM: The Role of LMA in Promoting Non-Animal Toxicity Testing

Replacing Animal Research
UK
The Replacement Checklist: A simple guide to prioritising non-animal methods

 


傑出青年學者獎

Dr Fadoua El Abdellaoui Soussi
Cincinnati Children’s Hospital Medical Centre, USA
Combining AI and Human Organoids to Improve Animal-Free Drug Induced Liver Injury (DILI) Prediction

Dowlette-Mary Alam El Din
Johns Hopkins Bloomberg School of Public Health, USA
Learning-on-Chip Model as the Next Step of Human-Relevant Models for Developmental Neurotoxicity Testing

Dr Adam Fellows
Royal Veterinary College, UK
Bioengineered Arteries to Replace Animal Use in Cardiovascular Research

Dr Daniela Flores Gomez
Institute for Risk Assessment Sciences, Utrecht University, Netherlands
Advancing animal-free endocrine and immune toxicology: an in vitro serum-free 3D adipose-immune model

Nathalia Stephanie Oliveira Nascimento
Federal University of Minas Gerais, Brazil
EV-Proteomics: Animal-Free NAM Platform for Mechanistic Assessment of Genotoxicity and Carcinogenicity Risk

Dr Luiz Carlos Maia Ladeira
University of Liège, Belgium
S2TOX: Mechanistic Assessment of Cardiotoxicity using Integrated In Silico and In Vitro Modeling

Dr Gloria Melzi
Università degli Studi di Milano, Italy
Beyond S9 mix: a human liver-based model to replace animal testing in genotoxicity assessment

Dr Alicja Mikolajczyk
University of Gdansk, Poland

Dr Kate Mintram
Brunel University London, UK
FishGAN: A Generative AI Model for Advanced Toxicity Prediction in Environmental Risk Assessments.

Dr Marion Revel
Eawag – Swiss Federal Institute of Aquatic Science and Technology, Switzerland
Describing the applicability domain of NAMs: a case study considering stakeholder perspectives to improve uptake of non-animal methods.

Jonne Rietdijk
Uppsala University, Sweden
Integrating multi-omics data to accelerate Adverse Outcome Pathway (AOP) development at scale

Dr Rahul Rimal
EMPA, Switzerland
Multi-compartment bioreactor-based models to mimic systemic toxicity in burns

Kristin Schüler
IST-ID – Institute of Bioengineering and Biosciences, Portugal
HER OA Model- Animal-origin free Female Endocrine Osteoarthritis Model for Personalized Therapy Screening

Dr Viola Sgarminato
Politecnico di Torino, Italy
Exocrine Pancreas In Vitro Complex (EPIC) Model: An Innovative, Fully Animal-Free Tool for Advancing Cancer Research

Dr Nicoleta Spînu
AI4Cosmetics, Netherlands
AI Copilot for Safety Assessment of Cosmetic Ingredients

Minh Tran
Sungkyunkwan University, South Korea
Humanized Gut–Brain–Vascular (hGBV)-on-a-Chip for Bidirectional Toxicology Screening in Gut-Neuropathogenesis